lab_safety_rep_rap_eval_etiq_08_2014-eng.xls

First Page		Document Content
Date: 2014-09-15 09:43:37 Alcohols Phenols Ketones Euphoriants Hydromorphone Purdue Pharma Morphine Buprenorphine Oxycodone Chemistry Organic chemistry Morphinans		lab_safety_rep_rap_eval_etiq_08_2014-eng.xls Add to Reading List Source URL: www.hc-sc.gc.ca Download Document from Source Website File Size: 74,67 KB Share Document on Facebook

	HRET HEN 2.0 PowerPoint Template DocID: 1rkHo - View Document
	Health Alliance Medicare HMO and PPOFormulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DocID: 1pLYD - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HYSINGLA ER safely and effectively. See full prescribing information for HYSINGLA ER. HYSINGLA ER (hydrocodone bitar DocID: 1pD7R - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION • Instruct patients to take XTAMPZA ER capsules with food in order to These highlights do not include all the information needed to use XTAMPZA ER safely and effectively. See full DocID: 1pwHV - View Document
	IPRC Indiana Prevention Resource Center OPIOIDS DocID: 1plfs - View Document